■ 学術雑誌
|
原著
|
|
1.
|
Daichi Fujimoto, Mitsuhiro Abe, Kenta Murotani, Mihoko Imaji Onishi, Yuki Sato, Eisaku Miyauchi, Eri Takase, Hisashi Tanaka, Takashi Kijima, Yoshihiko Taniguchi, Ayumu Otsuki, Jun Sugisaka, Hiroshi Yokouchi, Daisuke Arai, Yoshihiko Sakata, Motohiro Tamiya, Satoru Miura, Hidekazu Suzuki, Hirotaka Matsumoto, Moon H Hwang, Teppei Yamaguchi, Asuka Okada, Satoshi Watanabe, Ryota Shibaki, Yuichiro Kikawa, Keisuke Tomii, Hiromitsu Sumikawa, Nobuyuki Yamamoto, Hiroaki Akamatsu：
Three versus six weeks of corticosteroids for mild immune-related pneumonitis: a randomized trial.
American journal of respiratory and critical care medicine
：Online ahead of print
, 2026
|
|
2.
|
Manami Tada, Yuichiro Kikawa, Nobuhiro Shibata, Chie Hirai, Hirotsugu Yanai, Masahiro Takada, Tomoharu Sugie：
Efficacy of olanzapine for prophylaxis of delayed chemotherapy-induced nausea and vomiting in patients with breast cancer receiving dose-dense AC with a steroid-sparing regimen: a single-center pilot study.
BMC cancer
26
(1)
：625
, 2026
|
|
3.
|
Yosuke Aoyama, Kosuke Kashiwabara, Yuichiro Kikawa, Naruto Taira, Hirofumi Mukai, Masato Takahashi：
Minimal important differences of EORTC QLQ-C30 and QLQ-BR23 for metastatic breast cancer patients in a Japanese population: results from the RESQ trial.
Breast cancer (Tokyo, Japan)
33
(3)
：752
-760
, 2026
|
|
4.
|
Tomoe Taji, Yukari Uemura, Yuri Kimura, Noriko Maeda, Aki Ito, Hirohito Seki, Daisuke Takabatake, Michiko Harao, Shogo Nakamoto, Ryoichi Matsunuma, Chinatsu Koganezawa, Takayuki Iwamoto, Hirofumi Mukai, Yuichiro Kikawa：
Real-world uptake of gBRCA testing as a companion diagnostic for olaparib in patients with high-risk HER2-negative early breast cancer in Japan: a cross-sectional multicenter study (BRCAwareness).
Breast cancer (Tokyo, Japan)
33
(4)
：919
-927
, 2026
|
|
5.
|
Kazutaka Narui, Kana Miyahara, Yukari Uemura, Akimitsu Yamada, Kazuhiro Araki, Fumie Fujisawa, Takahiro Nakayama, Takashi Ishikawa, Hirohito Seki, Kimito Yamada, Masahiro Kitada, Takayuki Iwamoto, Naruto Taira, Yuichiro Kikawa, Tomohiko Aihara, Hirofumi Mukai：
Abemaciclib plus endocrine therapy in chemotherapy-treated patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer.
Breast cancer (Tokyo, Japan)
：Online ahead of print
, 2026
|
|
6.
|
Takashi Ishikawa, Yukari Uemura, Hirohito Seki, Masahiro Kitada, Tsuyoshi Saito, Kimito Yamada, Shintaro Takao, Daisuke Takabatake, Toru Yokota, Miyuki Kitahara, Yuichiro Kikawa, Akimitsu Yamada, Uhi Toh, Hideki Nishimura, Hiroshi Kaise, Kazuhiro Yamagami, Reiki Nishimura, Naruto Taira, Kazutaka Narui, Hirofumi Mukai：
Real-world data for a CDK4/6 inhibitor, palbociclib, as 1st- or 2nd-line therapy in HR+/HER2- metastatic breast cancer: a multicenter prospective cohort study.
Breast cancer research : BCR
：Online ahead of print
, 2026
|
|
7.
|
Tatsunori Shimoi, Nobuhiro Shibata, Masahiro Kitada, Michiko Tsuneizumi, Mitsugu Yamamoto, Yukinori Ozaki, Yumi Fujimoto, Sayuri Akiyoshi, Naoki Hashimoto, Miki Yamaguchi, Yutaka Yamamoto, Norikazu Masuda, Hiroshi Tada, Takashi Yamanaka, Yuichiro Kikawa, Tetsuhiko Taira, Shizuka Nakagawa, Taizo Takashashi, Mari S. Oba, and Naoki Niikura.：
Prospective observational study of atezolizumab plus nab-paclitaxel in patients with metastatic triple-negative breast cancer: JBCRG-C08/ATTRIBUTE.
NPJ Breast Cancer
：Online ahead of print
, 2026
|
|
